The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...
The FDA has approved UCB’s Kygevvi (doxecitine and doxribtimine) to treat genetic mitochondrial disease, thymidine kinase 2 ...
Gov. Hobbs launched the AZRx initiative to help residents save money on prescription drugs through the free ArrayRx discount ...
The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and ...
MedPage Today on MSN
Ultra-Rare Mitochondrial Disease Gets First FDA-Approved Drug
The FDA approved doxecitine and doxribtimine powder (Kygevvi) for thymidine kinase 2 deficiency (TK2d), an ultra-rare mitochondrial depletion syndrome, the agency announced on Monday. A pair of ...
A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...
In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug ...
FDA approves first drug for TK2 deficiency, giving hope to patients with rare mitochondrial disorder
In a historic medical breakthrough, the US Food and Drug Administration (FDA) has approved KYGEVVI—a combination of ...
Dr. George Tidmarsh, who led the FDA’s drug division, was accused in a lawsuit Sunday of retaliating against pharmaceutical ...
Dilbert” creator Scott Adams announced earlier this year he had been diagnosed with a metastasized prostate cancer. In a post ...
FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application CervoMed is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback